-
- Watanabe Masataka
- Department of Cardiology, Tokyo Medical University
-
- Takata Yoshifumi
- Department of Cardiology, Tokyo Medical University
-
- Fukasawa Shinya
- Department of Cardiology, Tokyo Medical University
-
- Sakota Kunihiro
- Department of Cardiology, Tokyo Medical University
-
- Abe Tetsuya
- Department of Respiratory Medicine, Tokyo Medical University
-
- Goseki Yoshinari
- Department of Cardiology, Tokyo Medical University
-
- Setoguchi Yasuhiro
- Department of Respiratory Medicine, Tokyo Medical University
-
- Chikamori Taishiro
- Department of Cardiology, Tokyo Medical University
-
- Yamashina Akira
- Department of Cardiology, Tokyo Medical University
この論文をさがす
説明
Two patients developed bepridil-induced interstitial pneumonia during treatment of arrhythmia. The first patient was a 69-year-old man who received bepridil to maintain sinus rhythm in atrial fibrillation and who developed dyspnea on the 20th day after administration. The second patient was a 72-year-old man who received bepridil for paroxysmal atrial fibrillation and who developed dyspnea on the 60th day after administration. They were diagnosed with interstitial pneumonia on the basis of physical and imaging findings. The first patient was discharged after steroid pulse therapy, and the second patient after improvement of physical and imaging findings when bepridil was discontinued. Although a limited number of cases of bepridil-induced interstitial pneumonia have been reported, the disorder should be kept in mind as an important adverse reaction when breathlessness or dyspnea develops during administration of the drug. (Circ J 2009; 73: 1352-1355)<br>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 73 (7), 1352-1355, 2009
一般社団法人 日本循環器学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282680080259200
-
- NII論文ID
- 10025933003
-
- NII書誌ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可